Teladoc Health (NYSE:TDOC) Announces Earnings Results, Misses Estimates By $0.07 EPS

Teladoc Health (NYSE:TDOC) announced its quarterly earnings data on Wednesday. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by ($0.07), Zacks reports. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. Teladoc Health updated its Q1 2025 guidance to -0.400–0.150 EPS and its FY 2025 guidance to -1.100–0.500 EPS.

Teladoc Health Trading Down 2.5 %

NYSE TDOC traded down $0.28 on Wednesday, reaching $10.91. The stock had a trading volume of 10,466,903 shares, compared to its average volume of 8,008,443. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. The stock has a fifty day moving average price of $10.58 and a two-hundred day moving average price of $9.52. Teladoc Health has a 12-month low of $6.76 and a 12-month high of $15.95. The firm has a market capitalization of $1.88 billion, a price-to-earnings ratio of -1.89 and a beta of 1.04.

Analysts Set New Price Targets

TDOC has been the subject of a number of analyst reports. TD Cowen dropped their price target on Teladoc Health from $9.00 to $8.00 and set a “hold” rating for the company in a research report on Thursday, October 31st. Bank of America upped their target price on Teladoc Health from $11.50 to $13.50 and gave the company a “neutral” rating in a report on Wednesday, February 12th. Royal Bank of Canada raised their target price on Teladoc Health from $11.00 to $12.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. Deutsche Bank Aktiengesellschaft boosted their price target on shares of Teladoc Health from $10.00 to $12.00 and gave the company a “hold” rating in a research report on Friday, November 1st. Finally, Oppenheimer cut their price objective on shares of Teladoc Health from $14.00 to $12.00 and set an “outperform” rating for the company in a research report on Friday, January 24th. Thirteen investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $11.81.

Insider Transactions at Teladoc Health

In other news, insider Carlos Nueno sold 2,389 shares of the firm’s stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $11.93, for a total value of $28,500.77. Following the completion of the transaction, the insider now owns 2,890 shares of the company’s stock, valued at approximately $34,477.70. This trade represents a 45.25 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Company insiders own 0.95% of the company’s stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.